Lundbeck Executive Vice President, Supply Operations & Engineering, Lars Bang : "We are particularly pleased to establish a base in the Alpes-Maritimes and particularly within Sophia Antipolis, which has been a center for innovation for almost 40 years”. Read the full news
The Côte d'Azur boasts international success stories in pharmaceuticals, medical instruments, imagery, biomedical technologies, veterinary medicine and agronomy. Today, it is home to innovative science clusters in ophthalmology, oncology and neurology.
The Côte d'Azur offers life sciences companies an unparalleled scientific and industrial setting. It is one of the few regions in the world with so much expertise in both the health sector and IT technologies.
With a wealth of talent in areas as diverse as the pharmaceutical industry, medical instruments, imaging, biomedical technologies, the veterinary industry and agronomics, companies find it easy to hire top engineers and researchers.
Some 2,000 researchers are based here at leading private and French state-run research institutes.
- The Nice Teaching Hospital is the largest hospital development project underway in France. The new facility will usher in a new generation of research and public health hospitals and will make space available to private research teams.
- The Head and Neck Cancer Institute is a leading center in head and neck oncology and surgery.
- The Institute of Molecular and Cellular Pharmacology (IPCM) is adding a new pavilion for Neurology and Alzheimer's disease.
- The Claude Pompidou Foundation is building a pilot center for healthcare, research and prevention in Nice.
EUROBIOMED is one of France's 8 national competitiveness clusters in health and biotechnologies. It brings together key players in the Provence-Alpes-Côte d'Azur and Languedoc-Roussillon regions to work on 5 main themes:
- Fight infectious, tropical and emergent diseases
- Fight rare and orphan diseases
- Medical tequipments: Biomarkers, diagnosis in vitro
- Immunology and its therapeutic applications
- The neurological pathologies, ageing and disability
Interview with Nadia BOEHRINGER, Associate Director Regulatory Affairs & Business Development for EUDRAC France in Sophia Antipolis
Louis Vuitton (LVMH Group), plans to establish its perfume creation workshop by 2014
Iris Pharma and RxGen Partner to Deliver Seamless and Superior Drug & Medical Devices Development Services in Ophthalmology
Stéphane Diagana presented his project to the press on 22nd March
Pierre Escoubas, CEO/Founder of VenomeTech, will be the guest at the StartUp show presented by Jean-Pierre Largillet, on Thursday 19th April from 5.00pm
"Sophia-Antipolis is a very attractive region for any semiconductor company, for several reasons. The first one is that in the technology park of Sophia-Antipolis there is a solid tradition of analog and digital design, which is due to the presence of other big companies working in the same or similar markets, like Texas Instruments, Intel, STM and others. The second reason is linked to presence in the technology park of the Polytech'Nice-Sophia and other important schools.
That will guarantee our future growth since the region will always offer both experienced design engineers and you talents to hire."
Interview with Paolo Cusinato, Design Director of MAXIM Sophia-Antipolis design center

•Business Unit Manager
Annual turnover: 2.3 billion euros
Companies: 245
Jobs: 9,130
Fields of activity: Biotechnologies, Biomaterials, Chemistry, Cosmetology, Biomedical Engineering, Health Image and Software, Medical Instrumentation, Pharmaceutical & Veterinary Industrie, Pharmacology, Agronomy.
Leaders: Arkopharma, Asepta, Bayer Cropsciences, CLL Pharma, Dow Agrosciences, Galderma, IRIS Pharma, Integra Neurosciences Implants, Laboratoires Boiron, Laboratoires Genévrier, Lundbeck/Elaiapharm, MXM, NicOx, Txcell, Virbac
Success Stories: Iris Pharma, Median Technologies, Neomah, Neurelec, Nicox, Quantificare, Senseor, Virbac, Theralpha, Txcell, VenomeTech,...
Competitive Clusters : EUROBIOMED Biocluster